Category

Zoloft

New Study: Celexa & Zoloft Disrupt Unborn Baby Bone Growth

By | Pharmaceutical litigation, Uncategorized, Zoloft

topamax_birth_defects_topamax_lawsuit_settlementsCelexa and Zoloft, two drugs used to treat depression, are linked to many types of birth defects. And according to a recently published study, these two antidepressants are now linked to poor bone development.

The study, Citalopram and sertraline exposure compromises embryonic bone development, appeared in Molecular Psychiatry in September 2015.

The researchers looked at bone development in zebrafish embryos and human adult stem cells.

In both cases, they discovered that exposure to either Celexa (citalopram) or Zoloft (sertraline) resulted in inhibited bone growth.

In concluding their findings, the researchers emphasized that, “[t]hese results highlight the need to further investigate the risks of SSRI use during pregnancy in exposing unborn babies to potential skeletal abnormalities.”

WE CAN HELP YOU

Do you have questions about use of antidepressants like Celexa and Zoloft during pregnancy?

If so, contact the law offices of Carey Danis & Lowe. Our team includes experienced trial attorneys and medical professionals, who are both available to answer your questions and discuss your concerns.

If you used a selective serotonin reuptake inhibitor (SSRI) antidepressant, such as Celexa or Zoloft, during your pregnancy, and your child was born with birth defects, we encourage you to contact one of our SSRI birth defect lawyers today.

We offer free case evaluations, and can help you decide whether filing a Celexa or Zoloft birth defect lawsuit is right for you and your family.

Contact Carey Danis & Lowe today.

You can reach us by phone at 800.721.2519, or by completing a confidential personal injury claim form.

 

 

First Zoloft Birth Defects Lawsuit to Go to Trial: What Pfizer Knew

By | Pharmaceutical litigation, Uncategorized, Zoloft

Zoloft MDL Updates: Zoloft MDL No. 2342 Progresses with Order to Submit Initial Discovery Zoloft Birth Defect CasesPfizer knew about the link between Zoloft use during pregnancy and birth defects in newborn babies. However, they decided to ignore this crucial patient safety information. A lawyer in the first Zoloft birth defects lawsuit to go to trial shared this with the jury during closing arguments in a state court in St. Louis on April 17, 2015.

The lawyer pointed specifically to an internal document dating before 1991 that included the recommendation that women able to become pregnant shouldn’t use Zoloft due to birth defect risks.

Furthermore, the lawyer argued that, even with knowledge of Zoloft and birth defects risks, Pfizer made no move to issue a sufficient warning. Pfizer didn’t update Zoloft’s drug safety label; therefore, doctors and patients were left in the dark about the dangers of Zoloft use during pregnancy.

The lawyer represents the plaintiffs in the case, the Pesante family, whose son was born with heart defects after his mother consumed Zoloft during pregnancy.

The son’s heart defects required three open-heart surgeries. Only a month after being born, the boy received a pacemaker.

In a Bloomberg article about the Zoloft trial, the defendants argued in their closing statement that Pfizer did issue warnings, and that these warnings were approved by the U.S. Food and Drug Administration (FDA).

Now, it is up to the jury to decide if Pfizer did indeed issue a sufficient warning, or if the company should be held liable for the harm done to the Pesante family and their son.

We can help your family

Carey Danis & Lowe is a St. Louis law firm that currently represents families whose children have been harmed by Zoloft in the womb. Our defective drug lawyers work tirelessly to recover losses for our clients.

If you would like to discuss your case with us, we are available by phone at 800.721.2519; you can also reach us by completing a confidential personal injury claim form.

We offer free case evaluations, and can help you decide if filing a Zoloft lawsuit is the right decision for you and your family.

 

 

The Link between Zoloft and Birth Defects

By | Pharmaceutical litigation, Uncategorized, Zoloft

Zoloft MDL Updates: Zoloft MDL No. 2342 Progresses with Order to Submit Initial Discovery Zoloft Birth Defect CasesAt the first trial of 1000+ Zoloft birth defects lawsuits, the plaintiff’s legal team presented evidence that Pfizer researchers knew that pregnant women using Zoloft risked having babies with heart defects.

Zoloft is the most popular antidepressant on the market.

Pfizer overlooked internal red flags about possible birth defects to preserve billions in the sales of Zoloft, say families suing the drug giant. Pfizer didn’t use this research to caution doctors and patients about the risk, said the plaintiff’s lawyer at state court in St. Louis.

Zoloft Studies

A New England Journal of Medicine study in 2007 documented that pregnant women on Zoloft had double the risk of having a child with a birth defect.

According to Pfizer’s study, risks to newborns range from atrial septal defect, heart disease, growth retardation, omphalocele (newborns’ organs are outside their body), and persistent pulmonary hypertension.

The plaintiff in the case, Logan Pesante, whose mother took Zoloft while Logan was in the womb, has had three open heart surgeries to fix defects. The now 11-year old continues to suffer from lingering issues stemming from the defects.

The Pesantes and their lawyers argue that Pfizer needs to be held liable for failure to clearly warn physicians and patients about Zoloft’s increased risk of birth defects on the drug’s label and in marketing materials.

Legal Assistance

When drug makers don’t warn about a drug’s hazards, innocent consumers can suffer devastating effects. Drug manufacturers have a responsibility to test their products for health risks and advise the public. When they fall down in these duties, they face legal liability for the harm they cause.

If your baby has suffered heart wrenching pain due to a birth defect caused by Zoloft, Carey Danis & Lowe can help you. Our attorneys will assist in determining your eligibility to receive compensation for you and your baby. Our experienced lawyers are compassionate, knowledgeable and determined.

Carey Danis & Lowe is dedicated to representing individuals harmed by corporate abuse and neglect. Please call today for a free consultation—800.721.2519, or send us an email.

UCLA SSRI Study Examines Pregnancy & Drugs

By | Lexapro, Paxil, Pharmaceutical litigation, Prozac, Uncategorized, Zoloft

ssri_birth_defectsA UCLA study published in December 2014 examined the use of selective serotonin reuptake inhibitors, or SSRIs, during pregnancy. The researchers used lab mice to observe the effects of SSRI exposure in the womb, and how it impacts adult mice.

They observed that adult mice exposed to the SSRI, Lexapro, experienced a permanent change in serotonin transmission, whereas those adult mice exposed to Prozac in the womb, showed no signs of this permanent change.

The UCLA study examined a new side of SSRIs and pregnancy, one documenting the longterm implications of SSRI exposure in the womb, rather than the immediate.

The immediate implications of SSRI exposure in the womb, to a certain degree, are already known. Children have been born with life-changing congenital birth defects. These birth defects include atrial septal defects, ventricular septal defects, Omphalocele, Craniosynostosis, and persistent pulmonary hypertension of the newborn (PPHN).

Carey Danis & Lowe Can Help

Carey Danis & Lowe is a national law firm with a strong reputation for expertly assisting families through the challenges of recovering losses after a child has been born with SSRI birth defects. Our defective drug lawyers understand the pain and suffering these children and their families endure, and are available to help.

Explore your legal options and compensation eligibility today during a free, no-obligation case evaluation.

Contact Carey Danis & Lowe by phone at 800.721.2519, or submit a confidential personal injury claim form.

We look forward to offering you and your family any assistance that we can.

Zoloft Birth Defects Lawsuit Update: Latest Developments in Pennsylvania Zoloft MDL

By | Antidepressant, Pharmaceutical litigation, Uncategorized, Zoloft

SSRI Antidpressant Zoloft Birth Defects LitigationThe latest development to come out of the Zoloft birth defects multidistrict litigation (MDL) in the U.S. District Court for the Eastern District of Pennsylvania involves a back and forth between the plaintiffs and the federal judge handling the MDL. Their discussion involves discovery pool and trial pool case selections.

U.S. District Judge Cynthia M. Rufe is presiding over the Zoloft MDL. In late August, she submitted a trial pool selection guideline. In early September, the plaintiffs filed an objection of Judge Rufe’s selection guidelines, taking issue with the defendants’ ability to remove cases from the discovery pool.

The plaintiffs requested that Judge Rufe update her protocol so that the defendants are unable to remove, or strike, cases from the discovery pool submitted by the same plaintiffs’ legal counsel. The plaintiffs made this request on the basis of maintaining a variety of cases in the initial discovery pool, especially as it pertains to the plaintiffs’ legal counsel.

In the court document about this matter, Judge Rufe stated that the selection process for the discovery and trial pools should not involve reference to the plaintiffs’ legal counsel, as this does not necessarily provide a representative case.

The goal in selecting cases for the discovery and trial pools is to find a representative case suitable for a bellwether trial that supports an efficient legal process, and will aid in post-trial settlement.

Ultimately, Judge Rufe came to the conclusion that the defendants cannot remove two cases from the discovery pool whose plaintiffs are represented by the same legal counsel.

Carey Danis & Lowe Zoloft birth defects lawyers are keeping a watchful eye on the Zoloft MDL as it inches closer and closer to the bellwether trial process. Above all, the multidistrict litigation process makes for an efficient legal process. In regards to the most recent court filing in the Zoloft birth defects MDL, Carey Danis & Lowe hopes that the latest ruling is in keeping with this core purpose.

Carey Danis & Lowe is currently accepting Zoloft birth defects cases. Contact Carey Danis & Lowe today for a free legal consultation about your case, and to determine if you and your family are be eligible for compensation. Our Zoloft attorneys can also assist in filing Zoloft birth defects lawsuits.

If you have questions about Zoloft birth defects, voice your questions and concerns to one of our on-staff nurses.

Share your Zoloft birth defects story with Carey Danis & Lowe by calling 800.721.2519, or by submitting a personal injury claim form.

Zoloft Birth Defects Lawsuit Review

By | Pharmaceutical litigation, Uncategorized, Zoloft

SSRI Antidpressant Zoloft Birth Defects LitigationA court document filed in July in the Zoloft multidistrict litigation (MDL) collected the latest information on Zoloft birth defects lawsuits pending across the U.S. According to the court document, in addition to the consolidated cases in the Pennsylvania Zoloft MDL, there are pending lawsuits in California, Illinois, Missouri, New York, and West Virginia.

In state courts across California, plaintiffs filed a total of 7 lawsuits in July 2013. There three cases pending in Illinois courts, with one lawsuit in St. Clair county involving eight families, and a 38 family case in the Southern District of Illinois.

In Missouri, there are three Zoloft lawsuits pending in courts, and in New York, there are five lawsuits pending in Oneida County and New York County. There is one case pending in the Circuit Court of Wayne County in West Virginia.

As of July 16, 2013, there are over 400 Zoloft lawsuits pending in the Zoloft MDL.

The Zoloft MDL is being heard in the U.S. District Court for the Eastern District of Pennsylvania, and is being overseen by U.S. District Judge Cynthia M. Rufe. The Zoloft MDL is In re: Zoloft (Sertraline Hydrochloride) Products Liability Litigation, MDL No. 2342. The first bellwether case is scheduled to come to trial in October 2014.

Women and their families have filed Zoloft birth defects lawsuits claiming that the use of Zoloft during pregnancy led to congenital birth defects. The most commonly reported birth defects are congenital heart defects, Omphalocele, Craniosynostosis, and persistent pulmonary hypertension of the newborn (PPHN). Visit the Zoloft birth defects information page for a complete Zoloft birth defects list.

Carey Danis & Lowe Zoloft birth defects lawyers work diligently to win justice for those who have been injured by negligent pharmaceutical companies. Our team of legal and medical experts are here to help. If you took Zoloft while pregnant, and your child was born with birth defects, depend upon Carey Danis & Lowe to win you justice and resolution to your troubles and suffering.

Contact Carey Danis & Lowe for a free legal evaluation and for medical advice by calling 800.721.2519, or by submitting a personal injury claim form.

Evidence Strengthens Link Between SSRI Antidepressants and Congenital Birth Defects

By | Lexapro, Paxil, Pharmaceutical litigation, Uncategorized, Zoloft

zoloft_heart_birth_defect_ssri_pregnancyAccording to a European health care expert, pregnant women who take a selective serotonin reuptake inhibitor (SSRI) antidepressant early in pregnancy increase their child’s risk twofold of developing a heart defect. Professor Stephen Pilling of the National Institute for Health and Care Excellence (NICE) recently told the BBC that the birth defects risks associated with SSRI antidepressants are on par, if not more severe, than those linked to alcohol or tobacco use by pregnant women.

Pilling went on to state that the warnings communicated to pregnant women taking an SSRI antidepressant will soon be updated to include information about the strong link between SSRIs and birth defects. In Pilling’s opinion, the risk of heart defects outweighs, in some cases, the risk to the pregnant mother in terms of whether to discontinue use of an SSRI antidepressant in early pregnancy.

Carey Danis & Lowe is a national law firm with attorneys that represent women and their families in SSRI birth defects lawsuits. Our SSRI birth defects lawyers view Pilling’s statements as positive news for women and their families who claim that their child’s birth defects are the result of exposure to an SSRI antidepressant.

If you or someone you love took an SSRI antidepressant during pregnancy, and your baby developed a heart defect, such as a hole in the heart, or other congenital birth defects, contact an SSRI birth defects lawyer at Carey Danis & Lowe.

Call 800.721.2519, and share your case with us.

Zoloft Lawsuit News: Injured Parties Continue to File Zoloft Birth Defects Lawsuits

By | Pharmaceutical litigation, Uncategorized, Zoloft

zoloft_heart_birth_defect_ssri_pregnancyAs a national law firm representing individuals in Zoloft birth defects lawsuits, Carey Danis & Lowe has closely been watching for news and updates in Zoloft lawsuits. Earlier this month, a plaintiff filed a Zoloft birth defects lawsuit in St. Clair County Circuit Court in Illinois claiming that her child was born with congenital heart defects. The plaintiff filed her Zoloft lawsuit citing that the maker of Zoloft, Pfizer, did not provide adequate warning about the risks associated with Zoloft use during pregnancy.

In response to the lawsuit, a Pfizer spokesperson was quoted in the Madison-St. Clair Record as saying that the pharmaceutical company intends to defend itself against the charges.

 Zoloft Birth Defects Background

In a study published in 2007 in the New England Journal of Medicine, researchers concluded that taking Zoloft (sertraline) during the first trimester of pregnancy led to two times the risk of the baby being born with a heart defect, especially a hole in the heart. In addition, the study found that the risk of a baby developing omphalocele was 5.7 times higher when exposed to Zoloft in the womb.

An atrial septal defect, also called a hole in the heart, is marked by an atypical hole between the heart’s two upper chambers. In newborn babies who develop a ventricular septal defect, a hole exists between between the heart’s two lower chambers. Omphalocele is a birth defect in which the newborn baby’s abdominal organs protrude from the belly button.

Carey Danis & Lowe Zoloft birth defects lawyers are currently taking Zoloft birth defects cases. For a free legal evaluation of your case and for assistance with filing a Zoloft birth defects lawsuit, contact Carey Danis & Lowe by calling 800.721.2519 or by submitting a personal injury claim form.

Carey Danis & Lowe Evaluating Zoloft Cases and Offers an Update on Zoloft Lawsuits in Zoloft MDL No. 2342

By | Pharmaceutical litigation, Uncategorized, Zoloft

Published January 14, 2013 by PR Web

St. Louis, Missouri (PRWEB) January 14, 2013

Zoloft MDL Updates: Zoloft MDL No. 2342 Progresses with Order to Submit Initial Discovery Zoloft Birth Defect CasesZoloft lawsuits have been consolidated into a Multi-District Litigation in the U.S. District Court for the Eastern District of Pennsylvania. Judge Cynthia M. Rufe is presiding over the Zoloft MDL.

As to recent developments in the Zoloft MDL, on January 2, 2013, Judge Rufe sent forth Pretrial Order No. 16. Fundamentally, the Pretrial Order outlines how to deliver responses in the MDL. The court document imparts detailed information as to “the procedure for filing responses to all civil actions that are or become consolidated in MDL No. 2342”.*

The Pretrial Order goes on to supply information on how the defendants, Pfizer Inc., Greenstone LLC, and Pfizer International LLC, shall go about filing a Master Short-Form Answer. In essence, the Master-Short Form Answer and Affirmative Defense is the defendants’ response to the claims of the plaintiffs.

According to the Pretrial Order, the Defendants will only have the opportunity to file one Master Short-Form Answer, and in doing so can address any and all charges made against them in each of the cases consolidated in the Zoloft MDL. As the document will stand as their initial response to allegations, Pfizer and Greenstone can deny the plaintiffs’ allegations, and in so doing, they can lay out a defense.

If relying upon information supplied in a recent report, there are quite a number of Zoloft cases in the MDL, and therefore each of these cases will necessitate address in the defense’s response. A Florida attorney who sits on the Plaintiffs’ Steering Committee (PSC), Bryan F. Aylstock, recently submitted a report late last year regarding the status of the Zoloft MDL. The legal journal, The Madison-St. Clair Record, stated that according to information contained in Alystock’s report, there are over 250 cases that have been consolidated into the Zoloft MDL.*

Plaintiffs in the Zoloft MDL have filed lawsuits against Pfizer, the manufacturer of Zoloft, claiming that the antidepressant drug, classified as a selective serotonin re-uptake inhibitor (SSRI), causes birth defects in newborn children when taken by women during pregnancy.

In a separate Zoloft lawsuit being heard in the Wayne County Circuit Court in West Virginia, nineteen plaintiffs, who are the children of mothers who claimed to have taken Zoloft during pregnancy, filed their lawsuit alleging that exposure to Zoloft in the womb resulted in the development of their birth defects.

According to the legal journal, The West Virginia Record, the plaintiffs identified these Zoloft linked birth defects as heart defects, such as atrial septal defects and holes in the heart, persistent pulmonary hypertension of the newborn (PPHN), skull and facial deformations, and a number of other congenital birth defects related to Zoloft exposure in utero.*

Lawyers at Carey Danis & Lowe are currently evaluating Zoloft cases, and they are offering legal consultations to those individuals who claim to have been harmed by the use of Zoloft during pregnancy. For more information about filing a Zoloft lawsuit, and specifically one related to Zoloft and birth defects, contact a lawyer at Carey Danis & Lowe by calling 800-721-2519.

Zoloft MDL No. 2342 Progresses with Order to Submit Initial Discovery Zoloft Birth Defect Cases

By | Pharmaceutical litigation, Uncategorized, Zoloft

Zoloft MDL Updates: Zoloft MDL No. 2342 Progresses with Order to Submit Initial Discovery Zoloft Birth Defect CasesThe Zoloft Multi-District Litigation No. 2342 being heard in the U.S. District Court for the Eastern District of Pennsylvania has made progress as regards setting the date for the first trial. According to Pre-trial Court Order 15, the first trial is currently scheduled for September 12, 2014. This is a tentative date that is dependent upon completion of all pertinent discovery by both sides.

This same court document from the Zoloft MDL details that by January 11, 2013, both the Defense and the Plaintiff’s counsel must deliver selections pertaining to Initial Discovery Group Cases, which will help in determining which cases enter the Trial Pool Cases.

The court has ordered that selections of cases that are representative enough for Trial Pool Cases should be supplied to the court by March 15, 2013.

According to a December 2012 article published by The Madison Record, there are currently 250 Zoloft cases that have been consolidated into the Pennsylvania MDL. What is more, there remain a number of Zoloft lawsuits pending in state courts that have not yet been consolidated into the MDL. State courts hearing these Zoloft lawsuits include Illinois, Missouri, New York, Pennsylvania, and West Virginia.

Plaintiffs in the Zoloft MDL claim that the use of Zoloft during pregnancy resulted in the development of birth defects in newborn children. These Zoloft birth defects include, but are not limited to, the following:

  • Congenital heart defects
  • Atrial septal defects
  • Ventricular septal defects
  • Omphalocele
  • Craniosynostosis
  • Persistent Pulmonary Hypertension of the Newborn (PPHN)

Zoloft is an anti-depressant drug manufactured by Pfizer. Zoloft is categorized as a selective serotonin re-uptake inhibitor, or SSRI. These types of antidepressants have a strong link to the development of birth defects in children exposed to an SSRI drug while in the womb.

If your newborn child was exposed to the SSRI medication Zoloft while in the womb, and as a result, developed life-altering and health compromising birth defects, you and your child may be entitled to receive recompense for your physical suffering, emotional suffering, and medical expenses.

For more information about filing a Zoloft birth defect lawsuit, contact an experienced trial lawyer at Carey Danis & Lowe. Our pharmaceutical product liability lawyers will provide you with a free legal consultation about your Zoloft case. Call a Zoloft lawyer at Carey Danis & Lowe today at 800.721.2519.